AMNHealthcare · Medical Care FacilitiesThe 9 Wall Street analysts covering AMN Healthcare Services, Inc. hold a median 12-month price target of $36 — -24.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 100 of 100 as at 4 Nov 2026 — among the strongest tenth. The factors read stronger than the Street's target implies. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores AMN Healthcare Services, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (98): Sales and profits are climbing, and climbing faster than before.
Volatility (49): The share price moves around a lot.
Size (36): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on AMN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits −24.6% from it.
Of the 20 most recent actions, 5 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Oct 2026 | BMO Capital | Maintains | Outperform | $40 → $43 |
| 11 Sept 2026 | BMO Capital | Maintains | Outperform | — |
| 11 Sept 2026 | BMO Capital | Maintains | Outperform | $38 → $40 |
| 14 Aug 2026 | Citizens | Maintains | Market Outperform | $36 → $40 |
| 14 Aug 2026 | Citizens | Maintains | Market Outperform | — |
| 7 Aug 2026 | UBS | Maintains | Neutral | — |
| 7 Aug 2026 | UBS | Maintains | Neutral | $32 → $35 |
| 22 July 2026 | Truist Securities | Maintains | Buy | $26 → $40 |
| 22 July 2026 | Truist Securities | Maintains | Buy | — |
| 23 June 2026 | Citizens | Reiterates | Market Outperform | — |
| 23 June 2026 | Citizens | Reiterates | Market Outperform | $36 |
| 13 May 2026 | UBS | Maintains | Neutral | — |
| 11 May 2026 | Baird | Maintains | Neutral | — |
| 11 May 2026 | BMO Capital | Maintains | Outperform | — |
| 8 May 2026 | Truist Securities | Maintains | Buy | — |
| 23 Feb 2026 | Citizens | Maintains | Market Outperform | — |
| 20 Feb 2026 | Baird | Maintains | Neutral | — |
| 20 Feb 2026 | UBS | Maintains | Neutral | — |
| 15 Jan 2026 | BMO Capital | Maintains | Outperform | — |
| 19 Dec 2025 | Citizens | Maintains | Market Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
AMN appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, AMN Healthcare Services, Inc. returned +142.3% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 41% of US stocks
Cheaper than 80% of US stocks
Cheaper than 36% of US stocks
Cheaper than 48% of US stocks
Higher than 33% of US stocks
Higher than 39% of US stocks
Higher than 35% of US stocks
Higher than 52% of US stocks
Higher than 55% of US stocks
Higher than 75% of US stocks
Higher than 73% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
AMN Healthcare Services, Inc. has a market value of $1.8B and an enterprise value of $2.2B.
Revenue in the twelve months to 30 June 2026: $3.4B. The latest quarter grew 2.3% year on year.
Net income over the same four quarters: $104.9M, a 3.1% net margin.
Diluted earnings per share, trailing twelve months: $2.68.
Free cash flow in the twelve months to 30 June 2026: $438.6M.
Trailing P/E: 17.8×; forward P/E: 50.9× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
AMN Healthcare Services, Inc. employs 2,664 people — $1.3M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own AMN Healthcare Services, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research explains how its Style Scores help investors identify highly rated stocks based on their investing style, and presents AMN Healthcare Services as a top value stock for the long term.
Why it matters — The item highlights Zacks' value-oriented framing of AMN and its Style Scores as tools for evaluating the stock.
Zacks Investment Research compares AMN Healthcare Services and Thomson Reuters as potential value options for investors interested in business-services stocks. The excerpt poses the question but does not provide a conclusion.
Why it matters — AMN watchers may note the comparison, though the excerpt does not indicate which stock offers better value.
Zacks Investment Research compares AMN Healthcare Services and Sodexo’s performance with their sector so far this year. The excerpt does not provide performance results.
Why it matters — AMN watchers may find the sector comparison relevant, but the excerpt does not say whether AMN outperformed.
AMN Healthcare shares rose 8.9% in the latest session on above-average trading volume. The latest trend in earnings estimate revisions does not suggest further strength ahead.
Why it matters — AMN watchers may note the sharp share-price move alongside the less supportive earnings-revision trend.
Zacks cites AMN Healthcare’s staffing demand, technology investments and growth prospects as supportive factors, while noting pricing pressure and weakness in some segments as challenges.
Why it matters — AMN watchers may weigh the company’s growth drivers against pricing and segment-related headwinds.
The 9 Wall Street analysts covering AMN Healthcare Services, Inc. have a median 12-month price target of $36, with estimates ranging from $28 to $43. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering AMN Healthcare Services, Inc., 3 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks AMN Healthcare Services, Inc. 100 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, AMN Healthcare Services, Inc. ranks 100 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (98 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies -24.6% from the last close, and Ticker Nerd's factor model ranks AMN Healthcare Services, Inc. 100 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering AMN Healthcare Services, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $28 to $43 over the next 12 months.
AMN Healthcare Services, Inc. returned +142.3% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
AMN Healthcare Services, Inc. is a healthcare workforce solutions and staffing company that supports hospitals, health systems, and other care providers across the United States.
The most recent item we track (Zacks Investment Research, 28 Oct 2026): "Why AMN Healthcare Services (AMN) is a Top Value Stock for the Long-Term". Zacks Investment Research explains how its Style Scores help investors identify highly rated stocks based on their investing style, and presents AMN Healthcare Services as a top value stock for the long term.
AMN Healthcare Services, Inc. is a healthcare workforce solutions and staffing company that supports hospitals, health systems, and other care providers across the United States. AMN Healthcare Services, Inc. offers a broad range of services that help organizations recruit, deploy, and manage clinical talent, including travel nurse staffing, allied health staffing, physician and locum tenens placement, interim leadership, and permanent recruitment. The company also provides technology-enabled workforce tools and managed services programs that assist clients with scheduling, vendor management, recruitment process outsourcing, language services, and predictive analytics. Its business is organized around Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions, reflecting its focus on both direct staffing and workforce management. AMN Healthcare Services, Inc. plays a significant role in helping healthcare employers address staffing needs, improve workforce flexibility, and support the delivery of care in a complex labor environment.
CEO Ms. Caroline Sullivan Grace · 2,664 employees · United States · https://www.amnhealthcare.com
